BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22208659)

  • 1. Epigenetics and Sjögren's syndrome.
    Le Dantec C; Varin MM; Brooks WH; Pers JO; Youinou P; Renaudineau Y
    Curr Pharm Biotechnol; 2012 Aug; 13(10):2046-53. PubMed ID: 22208659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics in Primary Sjögren's Syndrome.
    Bordron A; Devauchelle-Pensec V; Le Dantec C; Capdeville A; Brooks WH; Renaudineau Y
    Adv Exp Med Biol; 2020; 1253():285-308. PubMed ID: 32445100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic alterations in primary Sjögren's syndrome - an overview.
    Imgenberg-Kreuz J; Sandling JK; Nordmark G
    Clin Immunol; 2018 Nov; 196():12-20. PubMed ID: 29649576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Signatures of Salivary Gland Inflammation in Sjögren's Syndrome.
    Cole MB; Quach H; Quach D; Baker A; Taylor KE; Barcellos LF; Criswell LA
    Arthritis Rheumatol; 2016 Dec; 68(12):2936-2944. PubMed ID: 27332624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.
    Mavragani CP; Nezos A; Sagalovskiy I; Seshan S; Kirou KA; Crow MK
    J Autoimmun; 2018 Mar; 88():75-82. PubMed ID: 29074164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjögren's syndrome X-chromosome dose effect: An epigenetic perspective.
    Mougeot JL; Noll BD; Bahrani Mougeot FK
    Oral Dis; 2019 Mar; 25(2):372-384. PubMed ID: 29316023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modifications in salivary glands from patients with Sjögren's syndrome affect cytokeratin 19 expression.
    Konsta OD; Charras A; Le Dantec C; Kapsogeorgeou E; Bordron A; Brooks WH; Tzioufas AG; Pers JO; Renaudineau Y
    Bull Group Int Rech Sci Stomatol Odontol; 2016 Jun; 53(1):e01. PubMed ID: 27352422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells.
    Thabet Y; Le Dantec C; Ghedira I; Devauchelle V; Cornec D; Pers JO; Renaudineau Y
    J Autoimmun; 2013 Mar; 41():175-81. PubMed ID: 23478041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and epigenetics in primary Sjögren's syndrome.
    Imgenberg-Kreuz J; Rasmussen A; Sivils K; Nordmark G
    Rheumatology (Oxford); 2021 May; 60(5):2085-2098. PubMed ID: 30770922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of epigenetics in Sjögren's Syndrome.
    Konsta OD; Thabet Y; Le Dantec C; Brooks WH; Tzioufas AG; Pers JO; Renaudineau Y
    Front Genet; 2014; 5():71. PubMed ID: 24765104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantigen-targeting microRNAs in Sjögren's syndrome.
    Yang Y; Peng L; Ma W; Yi F; Zhang Z; Chen H; Guo Y; Wang L; Zhao LD; Zheng W; Li J; Zhang F; Du Q
    Clin Rheumatol; 2016 Apr; 35(4):911-7. PubMed ID: 26888739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Role of microRNAs and Long Non-Coding RNAs in Sjögren's Syndrome.
    De Benedittis G; Ciccacci C; Latini A; Novelli L; Novelli G; Borgiani P
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34208031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylation mediates genetic association with the major histocompatibility complex genes in Sjögren's syndrome.
    Chi C; Taylor KE; Quach H; Quach D; Criswell LA; Barcellos LF
    PLoS One; 2021; 16(4):e0248429. PubMed ID: 33886574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis.
    Reale M; D'Angelo C; Costantini E; Laus M; Moretti A; Croce A
    J Immunol Res; 2018; 2018():7510174. PubMed ID: 29977932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium.
    Lu Q; Renaudineau Y; Cha S; Ilei G; Brooks WH; Selmi C; Tzioufas A; Pers JO; Bombardieri S; Gershwin ME; Gay S; Youinou P
    Autoimmun Rev; 2010 Jul; 9(9):627-30. PubMed ID: 20452464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monozygotic twins with primary Sjögren's syndrome.
    Bolstad AI; Haga HJ; Wassmuth R; Jonsson R
    J Rheumatol; 2000 Sep; 27(9):2264-6. PubMed ID: 10990245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art.
    Talotta R; Sarzi-Puttini P; Atzeni F
    J Immunol Res; 2019; 2019():8567364. PubMed ID: 30723750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide DNA methylation sequencing reveals epigenetic features and potential biomarkers of Sjögren syndrome.
    Lu DQ; Yao XY; Ren YT; Zhang KY; Zhu XC; Hong T; Yu X; Xie ZM; Chen LY; Wang XC
    Int J Rheum Dis; 2023 Nov; 26(11):2223-2232. PubMed ID: 37740638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
    Tapinos NI; Polihronis M; Moutsopoulos HM
    Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis.
    Nezos A; Mavragani CP
    J Immunol Res; 2015; 2015():754825. PubMed ID: 26550578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.